& Porter, 1940] .
The analogues tested are related to pantothenic acid (I) in the folowing ways.
(a) Homologues. The belief that compounds so related might be inhibitory was based on the report of Robinson [1940] that a ,B-tri-substituted propionic acid was inhibitory to growth of Mycobacterium tuberculosis of which phthioic acid, a trisubstituted acetic acid, is a normal constituent. Inhibition of succinic dehydrogenase by malonate affords a further example, and more recently ethionine, C2H5 .S . CH2. CH2. CH(NH2JCOOH, has been found to limit bacterial growth by competition with methionine [Harris & Kohn, 1941] . y-Hydroxy-n-butyrylf--alanine, (II) , a bisnordesoxypantothenate; y-hydroxyn-valeryl-/3alanine (III) , an isonordesoxypantothenate; homopantothenate, (IV) and a desoxypantothenate (V) were accoidingly tested.
(b) Related olefin. Fildes [1941] showed that indoleacrylate inhibited bacterial growth by virtue of its relation to tryptophan. The structure of pantothenate precludes the production of an olefin by simple-elimination of H20 or NH3, but dehydrohomopantothenate (VI), which is so related to homopantothenate, was tested.
(c) Sulphonic acids and sulphonamide. Several models are available: Woods [1940] showed sulphanilamide inhibition to be related to p-aminobenzoic acid; some aliphatic oc-aminosulphonic acids inhibit by virtue of their relation to oc-aminocarboxylic acids [Mcllwain, 1941a] , and pyridine-3-sulphonic acid and its amide by their relation to nicotinic acid and derivatives [Mcllwain, 1940] . The latter instance served as model for Snell's [1941] production of an inhibitory analogue of pantothenic acid, which was published while these investigations were in progress. Analogue VII, which it is proposed to call pantoyltaurine (pantoic acid=oc:y-dihydroxy-3:f-dimethylbutyric acid) is the analogue investigated by Snell. Detailed results of its effects on pathogenic organisms have been reported elsewhere [Mcllwain, 1942b] and are referred to here for comparison only. In addition, the corresponding sulphonamide (pantoyltauramide, IX) and a homologue (homopantoyltaurine, VIII) have now been tested. Taurine and taurine amide, which are the sulphonic acid and sulphonamide corresponding to f-alanine, a component This work was undertaken in order to find therapeutically useful inhibiting agents, but opportunity was also taken to investigate the structural specificity of pantothenate for bacterial growth, and the manner in which it and the analogues act.
EXPERIMENTAL
The analogues were prepared by Dr J. W. Barnett & Mr F. A. Robinson [1942] . Compounds III, IV, VII, VIII and IX were racemates. (+)Pantothenate was supplied by Merck and Co., Inc. In testing, solutions were sterilized by filtration and these and -other materials added aseptically to the basal media described later, in a final volume of 10 ml. The highest concentration of inhibitor usually tested was 2 x 10-3M. The media -were then inoculated lightly (c. 100 organisms/ml.) and incubated at 370 in 5 % C02-air. The effects of the addenda were judged during the next 7 days by comparing the opacities of these cultures with those of controls grown at the same time. Other bacteriological details, concerning the organisms described here, have been given elsewhere [Mcllwain, 1942 b] . 418 A. Streptococcus haemolyticus This organism was shown to require pantothenate by fractionating a liver concentrate necessary for its growth in a casein hydrolysate medium [Mcllwain, 1939] and this pato--thenate-free basal medium has been used in the present work. Five streptococci representing groups A and C uniformly required the addition of 10-7M or more pantothenate for optimal growth.
The taurine analogues VII, VIII and IX, each completely inhibited the'organisms in the presence of 10-7M pantothenate, but different quantities of the different compounds were necessary. The inhibition produced by each analogue was related to pantothenate: it could be prevented by addition of a further quantity of it. Such addition need not be made immediately; after a day's incubation with minimal optimal pantothenate and an inhibitory quantity of pantoyltaurine, further pantothenate allowed growth in the usual time. The effect of the inhibitor is thus bacteriostatic rather than bactericidal. In the presence of adequate pantothenate and excess of a taurine analogue the organisms. therefore appear to be suffering from the same deficiency as in the absence of both. Reversal of the inhibition was investigated in detail in the case of pantoyltauramide and found to be specific, among known nutrients, to pantothenate. A concentration of' pantoyltauramide double that just necessary for bacteriostasis was not antagonized by higher concentrations of glucose, of 14 amino-acids, nicotinamide, aneurin, riboflavin, adermin, glutamine and biotin (which substances, like pantothenate, are necessary for growth of streptococci) or by pimelate, choline and p-aminobenzoate. The components.
of pantothenate, P-alanine and pantoate, were also ineffective. A similar high degree of specificity has been found with pantoyltaurine. It therefore appears that the aim of' limiting the organism's use of pantothenate has been achieved in these compounds. & Porter, 1941; Wright, McMahan, Cheldelin, Taylor, Snell & Williams, 1941] ; the activities of those tested in -antagonizing. pantoyltaurine are consistent with their pantothenate contents and with -in vivo activity of the inhibitor. Pantoyltauramide was equally inhibitory to anaerobic growth of streptococcus. y-Hydroxy-n-butyrylt.alanine and the corresponding valeryl derivative were the only -other analogues inhibitory to streptococcus (see Table 3 ). Their effects were small and not reversed by pantothenate; the compounds have been more fully studied in connexion with Bact. coli. The non-inhibitory analogues were examined for growth-promoting activity, by attempted growth of streptococcus on their addition to the pantothenatedeficient medium. The same small aptivities were found which are discussed under P. morgani.
B. Diplococcus pneumoniae The nutritional requirements of this organism are not yet defined, and the most satisfactory medium found for demonstrating the effects of the present compounds was that used for Strep. haemolyticus with the addition of choline (10-5M) and 2-5 % of plasma.
This latter contributed a small quantity of pantothenate sufficient only for little or no growth. Pantothenate was therefore added, and the organism's requirements were practically the same as is recorded in Table 1 for streptococci.
Pneumococci were slightly less susceptible than streptococci to inhibition by pantothenate analogues. No marked differences were found between different strains when representatives of TypesI, II and III were examined. y-Hydroxy-n-butyryl-fi-alanine was not inhibitory, but the taurine derivatives were so. The inhibitions of both pantoyltaurine and pantoyltauramide were not so intense as with streptococci but showed the same competitive character; the antipneumococcal indices of the compounds were 1000 and 10,Q00 respectively.
C. Corynebacterium diphtheriae
This organism is of particular interest in relationt.o pantothenate requirements as Evans et al. [1939] found that only certain exacting strains require the compound. Others are less exacting in that they can synthesize it if grown in the presence of fl-alanine; this compound, but not the whole pantothenate molecule, is essential for their growth.. Gradations from absolute need for pantothenate to its complete replacement by ,-alanine have been encountered in the present worh.
The basal medium [Mcllwain, 1942b] was similar to that used for. streptococcus. Results in an amino-acid medium were comparable in the cases examined. The effects of the analogues varied markedly with different strains, and as is shown in Table 2 were correlated with their pantothenate requirements. Inhibition with pantoyltauramide was strongest with the strains (G1, G1156 and GW1) which most needed pantothenate in growth, and did not occur with those (R7, R20) which were independent of added pantothenate. Strain G1156, miti8, grew with ,B-alanine in place of pantothenate more slowly than did GW1, and was affected by the analogues in a manner similar to Gl. Strain R20, gravis, grew as rapid1# with /3-alanine as with pantothenate, and was not inhibited by pantoyltauramiae; unlike R7, it was also not inhibited by y-hydroxy-n-butyryl-/3-alanine.
phenomena were encountered in normal and trained strains of Staph. aureus and Bact. typhosum: the normal strains required amino-acids and were inhibited by cx-aminosulphonic acids, while the trained strains, synthesizing their own amino-acids, were not inhibited [Mcllwain, 1941a; 1942a] . y-Hydroxy-n-butyryl-/3-alanine was also inhibitory to the C. diphtheriae strains (Table 2) to varying degrees, but its 'action was not entirely correlated with their pantothenate needs or with their susceptibilities to the taurine derivatives. Pantothenate did not reverse its inhibitions. The hydroxyvaleryl analogue also inhibited. D. Bacterium coli Four strains were examined and found to differ little in rate of growth or degree of inhibition. Added pantothenate did not accelerate their growth in the ammonium lactate medium of Fildes [1938] nor with the addeAda given elsewhere [McIlwain, 1941 b] though growth was suboptimal in the former case. The effects of the analogues were examined in the ammonium lactate medium and are summarized in Table 3 . y-Hydroxy-n-butyryl-f3-alanine and the valeryl derivative were the most effective inhibitors and the former was examined in detail. Its inhibition (10-3, 2 x 10-4M solution)
was not prevented by pantothenate concentrations of 10-8 to 2 x 10-3M. Its action, however, probably bears some relation to pantothenate as y-hydroxy-n-butyric acid and /3-alanine were not inhibitory in concentrations sufficient for complete inhibition by their condensation product. [Pelezar & Porter, 19401 and limiting quantities (c. 2 x 10-8M) of the compound were present during testing of the analogues.
Nevertheless no analogue in concentrations up to 2 x 10-3M reduced the rate or mass of growth of the organism, though reduction in the quantity of added pantothenate was immediately evident. This insensitivity made it possible to test the ability of the compounds to replace pantothenate in growth. y-Hydroxy-n-valeryl-fl-alanine, pantoyltaurine and homopantoyltaurine caused no growth in 2 x 10-3M solutions, and, as the organism is sensitive to 4 x l09M pantothenate, they have < 2 x 10-6 of the activity of pantothenate. y-Hydroxy-n-butyryl-/3-alanine, homopantothenate, dehydrohomopantothenate, desoxypantothenate and pantoyltauramide gave responses corresponding to c. 5 x 10-6 of their concentration of pantothenate. Responses sometimes varied in different specimens of the same compounds and these figures must be regarded as maximal. The A. Taurine analogues: specificity to organism. All organisms susceptible to pantoyltaurine are affected by pantoyltauramide and homopantoyltaurine where they have Biochem. 1942, 36 28 A423 424 HENRY McILWAIN been investigated. The susceptibilities of each organism to the three compounds are in the same order, pantoyltaurine being most inhibitory, pantoyltauramide less so and homopantoyltaurine least. This may be taken as indicating that the systems affected in streptococcus, C. diphtheriae and pneumococcus are similar. In strains of the latter organism, susceptibility followed pantothenate needs but P. morgani forms an exception to a further such generalization. It is thus unlikely that the systems affected by the taurine analogues are the same in all organisms, for while the quantities of pantothenate which exacting organisms need for optimal growth are approximately equal, the effects of a given inhibitor are markedly different (Table 4 ); e.g. P. morgani requires The sign -indicates that inhibition was not observed with the highest ratio tested.
* Calculated from the data of Snell [1941] . practically the same quantity of pantothenate as the sensitive streptococcus, which is inhibited by 1/100th of the quantity of pantoyltaurine to which morgani is insensitive. The interpretation favoured, and expressed in the antibacterial indices-that pantothenate and, e.g. pantoyltauramide have in different organisms different relative affinities for essential enzymes-does not in itself imply functional similarity or dissimilarity in such enzymes.
The insensitivity of organisms not needing pantothenate was discussed under Bact. coli and it was concluded that resistance is not due to secondary effects such as destruction of the inhibitor, but to inherent factors which were not the production of large quantities of pantothenate. Sensitivity in different organisms is not completely correlated with any morphological, biochemical or staining characteristic normally used in bacteriological classification. Indeed all gradations, from complete insensitivity to inhibition of the highest degree encountered, are exhibited by strains of the one organism, C. diphtheriae. A correlation so far without exception is that all sensitive organisms require added pantothenate for optimal growth. This was particularly well marked in the C. diphtheriae strains, though again pantothenate production by the resistant strains was insufficient to antagonize the effects of a taurine analogue on a sensitive organism. This suggests that pantothenate produced in situ is a more effective reversing agent than that added. It is conceivably produced in the right place at the right time, or a SPECIFIC BACTERIAL INHIBITION. IV higher derivative which may be the actual functioning compound is synthesized by a route not involving free pantothenate. Parallel cases are the insensitivity of trained staphylococcus and Bact. typhosum to oc-aminosulphonic acids, while their parent strains are inhibited in the presence of quantities of amino-carboxylic acids sufficient for normal growth. The same argument would apply to the'insensitivity of Bact. coli to pantoyltauramide, but that of P. morgani cannot so be explained. Among other inhibitors, pyridine-3-sulphonamide affects organisms requiring added nicotinic acid, but not one which does not need the compound. Sulphanilamide, however, inhibits organisms not needing added p-aminobenzoic acid, as well as those which do [Rubbo & Gillespie, 1942 [Hills, 1941] and Qbservations of the effects of substances on gross bacterial growth cannot be expected to be interpreted in terms of only the enzymes primarily affected [cf. Harris & Kohn, 1941] .
That pantoyltaurine is a-more effective inhibitor than its amide, pantoyltauramide, is in contrast to the greater inhibitory powers which sulphanilamide possesses over sulphanilic acid. The compound affected by sulphanilic acid, p-aminobenzoic acid, is, however, a slightly weaker acid (pK 4.9) than is pantothenic acid (pK 4.4), though properties of the whole molecules are probably involved [cf. Albert & Goldacre, 1942] . Inhibitions by pantoyltaurine and the amide are both of the same type, i.e. competitive, unlike those of pyridine-3-sulphonic acid and its amide, which usually differed in type [Mcllwain, 1940] [McIlwain, 1942b] for expecting pantoyltaurine to be active in vivo against susceptible organisms. This should apply also to pantoyltauramide in the case of streptococcus.
SUMMARY
Pantothenate must be supplied to many bacteria before growth will take place. The hypothesis that it is necessary because it takes part in enzyme reactions whose progress is necessary to growth is supported by the present findings. Pantothenate-needing organisms cause many diseases; there is more than enough pantothenate for their growth in animal tissues. It might, however, be possible to prevent them from using it: on the above hypothesis, pantothenate, to be used by an organism, must react with a particular part of it, and by analogy with other enzyme inhibitors it was expected that other compounds structurally related to pantothenate might displace it from the essential enzymes and prevent their functioning. Three such analogues did so, though they had less affinity for the enzymes than had pantothenate and needed to be present in many times its concentration to prevent growth. The compounds are pantoyltaurine, with an antistreptococcal index of 500 (i.e. 500 times the concentration of pantothenate present was required to prevent growth of streptococcus) and an antipneumococcal index of 1000; pantoyltauramide with values of 100 and 10,000 an:d homopantoyltaurine which is less active. Only organisms needing pantothenate have been found susceptible to these compounds; thus, exacting strains of C. diphtheriae are inhibited, but not those which do not need added pantothenate. Other analogues were inhibitory to several organisms not needing added pantothenate; they also may act by interfering with pantothenate metabolism as such organisms synthesized the compound. 
